Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Eisenhawer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pathogens (Basel, Switzerland)|March 27, 2024
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global AcceptanceRoland W Sutter, Martin Eisenhawer, Natalia A Molodecky, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
The Last Mile in Polio Eradication: Program Challenges and PerseveranceRocio Lopez Cavestany, Martin Eisenhawer, Ousmane M Diop, et al.
Inorganic Chemistry|October 23, 1996
Synthesis, Properties, and Crystal Structures of Benzene-1,2-dithiolato Complexes of Thallium(I) and -(III)Boris E. Bosch, Martin Eisenhawer, Berthold Kersting, et al.
Vaccine|March 21, 2022
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experienceGrace R Macklin, Corey Peak, Martin Eisenhawer, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2022
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021Javier Martin, Cara C Burns, Jaume Jorba, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pathogens (Basel, Switzerland)|March 27, 2024
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global AcceptanceRoland W Sutter, Martin Eisenhawer, Natalia A Molodecky, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
The Last Mile in Polio Eradication: Program Challenges and PerseveranceRocio Lopez Cavestany, Martin Eisenhawer, Ousmane M Diop, et al.
Inorganic Chemistry|October 23, 1996
Synthesis, Properties, and Crystal Structures of Benzene-1,2-dithiolato Complexes of Thallium(I) and -(III)Boris E. Bosch, Martin Eisenhawer, Berthold Kersting, et al.
Vaccine|March 21, 2022
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experienceGrace R Macklin, Corey Peak, Martin Eisenhawer, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2022
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021Javier Martin, Cara C Burns, Jaume Jorba, et al.
Pageof 1